Global Strain and Mechanical Dispersion May Predict Death and Ventricular Arrhythmias Better Than Ejection Fraction
NCT ID: NCT02286908
Last Updated: 2023-11-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
3100 participants
OBSERVATIONAL
2014-06-30
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Echocardiographic Assessment and CLInical imPlication of Functional tricuSpid rEgurgitation in Heart Failure With Reduced or Preserved Ejection Fraction
NCT05209919
Ventricular-Vascular Coupling in Heart Failure
NCT00207220
Karolinska-Rennes (KaRen) Prospective Study of Exercise Stress Echocardiography in Heart Failure With Preserved Ejection Fraction
NCT00774709
Prevalence and Prognostic Relevance of Tricuspid Regurgitation in Different Heart Failure Entities
NCT04570098
Cardiac Elastography to Determine Strain and Strain Rates in the Heart
NCT00205387
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
2. In patients who receive internal cardioverter defibrillator(ICD) the main aim is to investigate if mechanical dispersion may predict ventricular arrhythmias better than EF.
3\) No interventions,only evaluation of the measurements obtained with transthoracic echocardiography.
4\) Follow up for 3 years, extended from 3 to 5 years.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. myocardial infarction
2. heart failure( defined as heart failure symptoms: reduced left ventricular function/ and or heart failure signs on chest x ray.
3. planned for primary prophylactic ICD
* over 18 years of age
* Informed consent
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
South-Eastern Norway Regional Health Authority
OTHER
Oslo University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Thor Edvardsen
Professor, Chief department of Cardiology Oslo university hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thor Edvardsen, MD, PHD
Role: STUDY_DIRECTOR
Oslo University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Vseobecna fakultni nemocnice Praha/ Prague General hospital
Prague, , Czechia
Sørlandet sykehus HF
Arendal, Agder, Norway
Vestre Viken HF
Drammen, , Norway
Sørlandet sykehus Kristiansand
Kristiansand, , Norway
Oslo university hospital
Oslo, , Norway
Sykehuset Telemark HF
Skien, , Norway
Stavanger universitetssjukehus
Stavanger, , Norway
Universitetssykehuset Nord Norge, Tromsø
Tromsø, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Erik Gjertsen
Role: primary
Tor Olav Isaksen
Role: primary
Jacob Thalamus
Role: primary
Dennis Nilsen
Role: primary
Pål Tande
Role: primary
Henrik Schirmer
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013/573/REK sør-øst
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.